Gateway Chemist,
334A Regents Park Road,
Finchley Central,
London N3 2LN UK

As the world continues to combat the COVID-19 virus, the vaccines developed by Moderna, Pfizer and Novavax have played vital roles in vaccinations campaign. But with the rollout of multiple COVID-19 vaccines, patient may wonder which option best suits their need.

Here is a comparison of these vaccines based on key factors

Efficacy

Pfizer: Demonstrated approximately 95% efficacy

Moderna: Reported around 94.1% efficacy in preventing symptomatic COVID-19

Novavax: Shows efficacy rates of 90% in clinical trials conducted in several countries

Technology

Moderna and Pfizer: Utilize mRNA technology, which provides instructions for cells to produce a spike protein found on the surface of the SARS-CoV-2 virus.

Novavax: Relies on a protein-based approach to stimulate an immune response.

Availability

Moderna: Is the vaccine administered through the NHS free of charge to eligible individuals in the Spring 2024 vaccination campaign. If you are eligible in this campaign you can book an appointment online here

Pfizer and Novovax:  Private healthcare providers offer these vaccines as an alternative option for individuals who are no eligible on the NHS. Private COVID-19 vaccination comes at a cost, the price can vary depending on the provider and the vaccine offered.  Patients interested in private vaccination can an appointment visiting Pharmadoctor or calling us directly on 0208 346 4530.

Each of these vaccines has shown effectiveness in combating COVID-19, contributing significantly to global vaccination efforts. It is important to consult healthcare providers to make informed decisions based on personal circumstances and NHS guidelines.


Leave a Reply

Your email address will not be published. Required fields are marked *